NASDAQ:MGTX - MeiraGTx News Headlines

Sign in or create an account to add this stock to your watchlist.
$24.35 +0.41 (+1.71 %)
(As of 05/26/2019 04:00 PM ET)
Previous Close$24.35
Today's Range$23.62 - $24.6451
52-Week Range$7.98 - $24.65
Volume130,565 shs
Average Volume151,123 shs
Market Capitalization$811.90 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

MeiraGTx (NASDAQ MGTX) News Headlines

Source:
DateHeadline
Why This Biotech Stock Looks Prime For A Johnson & Johnson BuyoutWhy This Biotech Stock Looks Prime For A Johnson & Johnson Buyout
finance.yahoo.com - May 17 at 3:56 PM
MeiraGTx (MGTX) Given Positive Rating at BarclaysMeiraGTx (MGTX) Given Positive Rating at Barclays
www.americanbankingnews.com - May 15 at 9:49 AM
MeiraGTx (MGTX) Releases Quarterly  Earnings Results, Beats Expectations By $0.02 EPSMeiraGTx (MGTX) Releases Quarterly Earnings Results, Beats Expectations By $0.02 EPS
www.americanbankingnews.com - May 15 at 8:26 AM
 Brokerages Set $27.67 Price Target for MeiraGTx Holdings PLC (MGTX) Brokerages Set $27.67 Price Target for MeiraGTx Holdings PLC (MGTX)
www.americanbankingnews.com - May 14 at 4:13 PM
MeiraGTxs (MGTX) "Buy" Rating Reaffirmed at Chardan CapitalMeiraGTx's (MGTX) "Buy" Rating Reaffirmed at Chardan Capital
www.americanbankingnews.com - May 14 at 2:36 PM
MeiraGTx gene therapy shows positive action in early-stage study in inherited eye disorderMeiraGTx gene therapy shows positive action in early-stage study in inherited eye disorder
seekingalpha.com - May 14 at 12:19 PM
MeiraGTx Reports First Quarter 2019 Financial Results and Provides Corporate UpdateMeiraGTx Reports First Quarter 2019 Financial Results and Provides Corporate Update
finance.yahoo.com - May 14 at 12:19 PM
MeiraGTx Appoints Nicole Seligman to Board of DirectorsMeiraGTx Appoints Nicole Seligman to Board of Directors
finance.yahoo.com - May 10 at 11:57 AM
 Brokerages Expect MeiraGTx Holdings PLC (MGTX) to Announce -$0.64 EPS Brokerages Expect MeiraGTx Holdings PLC (MGTX) to Announce -$0.64 EPS
www.americanbankingnews.com - May 9 at 12:40 PM
MeiraGTx to Present at Bank of America Merrill Lynch Healthcare ConferenceMeiraGTx to Present at Bank of America Merrill Lynch Healthcare Conference
finance.yahoo.com - May 7 at 11:47 AM
MeiraGTx Announces Upcoming Presentation on Achromatopsia Gene Therapy Candidate AAV-CNGA3 at ARVO 2019MeiraGTx Announces Upcoming Presentation on Achromatopsia Gene Therapy Candidate AAV-CNGA3 at ARVO 2019
finance.yahoo.com - April 26 at 11:40 AM
MeiraGTx Reports Full Year 2018 Financial ResultsMeiraGTx Reports Full Year 2018 Financial Results
finance.yahoo.com - March 27 at 12:48 PM
Johnson & Johnson Buys Large Stake in MeiraGTxJohnson & Johnson Buys Large Stake in MeiraGTx
finance.yahoo.com - March 11 at 3:55 PM
MeiraGTx to Present at the Barclays Global Healthcare ConferenceMeiraGTx to Present at the Barclays Global Healthcare Conference
finance.yahoo.com - March 7 at 12:42 PM
MeiraGTx Holdings PLCMeiraGTx Holdings PLC
www.barrons.com - February 27 at 3:51 PM
MeiraGTx up 6% premarket after pricing equity offeringMeiraGTx up 6% premarket after pricing equity offering
seekingalpha.com - February 27 at 12:14 PM
Chardan bullish on MeiraGTx after JNJ investment; shares up 14%Chardan bullish on MeiraGTx after JNJ investment; shares up 14%
seekingalpha.com - February 27 at 12:14 PM
MeiraGTx Announces $80 Million Private Placement of Ordinary SharesMeiraGTx Announces $80 Million Private Placement of Ordinary Shares
finance.yahoo.com - February 27 at 12:14 PM
MeiraGTx Appoints Martin Indyk, Ph.D. to Board of DirectorsMeiraGTx Appoints Martin Indyk, Ph.D. to Board of Directors
finance.yahoo.com - February 21 at 6:36 PM
MeiraGTx to Present at the BIO CEO & Investor ConferenceMeiraGTx to Present at the BIO CEO & Investor Conference
finance.yahoo.com - February 5 at 10:32 AM
MeiraGTx teams up with Janssen to develop gene therapies for inherited retinal disordersMeiraGTx teams up with Janssen to develop gene therapies for inherited retinal disorders
seekingalpha.com - January 31 at 11:21 AM
Janssen Enters Worldwide Collaboration and License Agreement with MeiraGTx to Develop Gene Therapy Programs for Inherited Retinal DiseasesJanssen Enters Worldwide Collaboration and License Agreement with MeiraGTx to Develop Gene Therapy Programs for Inherited Retinal Diseases
finance.yahoo.com - January 31 at 11:21 AM
MeiraGTx Enters into Strategic Collaboration with Janssen to Develop and Commercialize Gene Therapy Treatments for Inherited Retinal DiseasesMeiraGTx Enters into Strategic Collaboration with Janssen to Develop and Commercialize Gene Therapy Treatments for Inherited Retinal Diseases
finance.yahoo.com - January 31 at 11:21 AM
Do Directors Own MeiraGTx Holdings plc (NASDAQ:MGTX) Shares?Do Directors Own MeiraGTx Holdings plc (NASDAQ:MGTX) Shares?
finance.yahoo.com - January 4 at 3:33 PM
MeiraGTx to Present at the 37th Annual J.P. Morgan Healthcare ConferenceMeiraGTx to Present at the 37th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 2 at 10:46 AM
MeiraGTx Announces Publication of New Research Identifying Underlying Mechanism of Functional Improvement Seen with AAV-GAD Gene Therapy in Parkinson’s DiseaseMeiraGTx Announces Publication of New Research Identifying Underlying Mechanism of Functional Improvement Seen with AAV-GAD Gene Therapy in Parkinson’s Disease
finance.yahoo.com - December 12 at 10:52 AM
MeiraGTx Reports Third Quarter 2018 Financial Results and Provides Corporate UpdateMeiraGTx Reports Third Quarter 2018 Financial Results and Provides Corporate Update
finance.yahoo.com - November 8 at 9:15 AM
MeiraGTx nabs rights to gene therapy for dry eye & dry mouth disorderMeiraGTx nabs rights to gene therapy for dry eye & dry mouth disorder
seekingalpha.com - October 31 at 3:25 PM
MeiraGTx Announces Exclusive Licensing Agreement with National Institutes of Health for Gene Therapy Treatment for Sjögren’s Syndrome and Associated Xerostomia or XerophthalmiaMeiraGTx Announces Exclusive Licensing Agreement with National Institutes of Health for Gene Therapy Treatment for Sjögren’s Syndrome and Associated Xerostomia or Xerophthalmia
finance.yahoo.com - October 31 at 8:58 AM
MeiraGTx Holdings plc (MGTX) Names Katherine Breedis as CFOMeiraGTx Holdings plc (MGTX) Names Katherine Breedis as CFO
www.streetinsider.com - October 26 at 8:41 AM
MeiraGTx Expands Leadership Team with Appointment of Katherine Breedis as Chief Financial OfficerMeiraGTx Expands Leadership Team with Appointment of Katherine Breedis as Chief Financial Officer
finance.yahoo.com - October 25 at 8:45 AM
MeiraGTx Holdings plc (MGTX) Enters Collaboration with Johnson & Johnson Innovation to Develop Regulatable Gene Therapy TreatmentMeiraGTx Holdings plc (MGTX) Enters Collaboration with Johnson & Johnson Innovation to Develop Regulatable Gene Therapy Treatment
www.streetinsider.com - October 17 at 3:21 PM
MeiraGTx inks gene therapy research agreement with Johnson & JohnsonMeiraGTx inks gene therapy research agreement with Johnson & Johnson
seekingalpha.com - October 16 at 3:21 PM
MeiraGTx Enters Collaboration with Johnson & Johnson Innovation to Develop Regulatable Gene Therapy Treatment using MeiraGTx Riboswitch TechnologyMeiraGTx Enters Collaboration with Johnson & Johnson Innovation to Develop Regulatable Gene Therapy Treatment using MeiraGTx Riboswitch Technology
finance.yahoo.com - October 16 at 8:19 AM
MeiraGTx acquires Vector Neurosciences in all-stock dealMeiraGTx acquires Vector Neurosciences in all-stock deal
seekingalpha.com - October 9 at 8:33 AM
MeiraGTx Announces Acquisition of Vector Neurosciences, Gains Phase 2 Gene Therapy Program for Parkinson’s DiseaseMeiraGTx Announces Acquisition of Vector Neurosciences, Gains Phase 2 Gene Therapy Program for Parkinson’s Disease
finance.yahoo.com - October 9 at 8:33 AM
MeiraGTx to Present at Upcoming ConferencesMeiraGTx to Present at Upcoming Conferences
finance.yahoo.com - October 3 at 8:12 AM
MeiraGTx Announces AAV-CNGA3 Granted Rare Pediatric Disease Designation by the U.S. FDA for the Treatment of AchromatopsiaMeiraGTx Announces AAV-CNGA3 Granted Rare Pediatric Disease Designation by the U.S. FDA for the Treatment of Achromatopsia
finance.yahoo.com - August 27 at 3:20 PM
MeiraGTxs AAV-CNGA3 granted Rare Pediatric Disease designation for the treatment of achromatopsiaMeiraGTx's AAV-CNGA3 granted Rare Pediatric Disease designation for the treatment of achromatopsia
seekingalpha.com - August 27 at 3:20 PM
Chardan Capital Markets Starts MeiraGTx Holdings plc (MGTX) at BuyChardan Capital Markets Starts MeiraGTx Holdings plc (MGTX) at Buy
www.streetinsider.com - August 23 at 3:19 PM
MeiraGTx adds to rally, up 10%MeiraGTx adds to rally, up 10%
seekingalpha.com - August 22 at 3:18 PM
MeiraGTx Holdings plc (MGTX) Announces AAV-CNGB3 Granted Fast Track DesignationMeiraGTx Holdings plc (MGTX) Announces AAV-CNGB3 Granted Fast Track Designation
www.streetinsider.com - August 20 at 3:18 PM
MeiraGTx Announces AAV-CNGB3 Granted Fast Track Designation by U.S. FDA for Treatment of AchromatopsiaMeiraGTx Announces AAV-CNGB3 Granted Fast Track Designation by U.S. FDA for Treatment of Achromatopsia
finance.yahoo.com - August 20 at 3:18 PM
MeiraGTx gene therapy an Orphan Drug in U.S. for colorblindnessMeiraGTx gene therapy an Orphan Drug in U.S. for colorblindness
seekingalpha.com - August 13 at 3:18 PM
MeiraGTx Announces AAV-CNGA3 Has Received Orphan Drug Designation from the U.S. FDA for the Treatment of AchromatopsiaMeiraGTx Announces AAV-CNGA3 Has Received Orphan Drug Designation from the U.S. FDA for the Treatment of Achromatopsia
finance.yahoo.com - August 13 at 3:18 PM
MeiraGTx Reports Second Quarter 2018 Financial Results and Provides Corporate UpdateMeiraGTx Reports Second Quarter 2018 Financial Results and Provides Corporate Update
finance.yahoo.com - August 8 at 3:18 PM
[$$] Hotel REITs: HG Vora Checks In[$$] Hotel REITs: HG Vora Checks In
finance.yahoo.com - June 30 at 10:49 AM
MeiraGTx receives positive opinion for Orphan Drug Designation for AAV-CNGA3MeiraGTx receives positive opinion for Orphan Drug Designation for AAV-CNGA3
seekingalpha.com - June 26 at 3:15 PM
MeiraGTx Receives Positive Opinion for Orphan Drug Designation in the European Union for AAV-CNGA3 for the Treatment of AchromatopsiaMeiraGTx Receives Positive Opinion for Orphan Drug Designation in the European Union for AAV-CNGA3 for the Treatment of Achromatopsia
finance.yahoo.com - June 26 at 3:15 PM
MeiraGTx Announces MHRA Grants MIA (IMP) License for cGMP Manufacturing Facility in London, UKMeiraGTx Announces MHRA Grants MIA (IMP) License for cGMP Manufacturing Facility in London, UK
finance.yahoo.com - June 21 at 3:16 PM
This page was last updated on 5/26/2019 by MarketBeat.com Staff

Featured Article: Strangles

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel